EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Founder SDHB Exon 1 Deletion in Brazilian Patients with Paraganglioma: Further Evidence for An Iberian Founder Effect

Paula Bruna Araujo, João Bosco Nascimento, Mirna Sanchez Carvallo, Leandro Miranda-Alves, Delmar Muniz Lourenço, Erika O. Naliato, Mateus Henrique Veloso Miranda, Silvio H. da Cunha Neto, Ana Paula Aguiar Vidal, Mafalda Pinto, Paula Soares, Jorge Lima und 1 weitere

Current Genetic Medicine Reports · 19.08.2026 · 14 (1)

DOI: 10.1007/s40142-026-00260-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Genetic Medicine Reports, online erschienen am 19.08.2026. Verfasst von Paula Bruna Araujo und 12 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal Do Rio De Janeiro.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pheochromocytomas and paragangliomas (PPGLs) are highly heritable neuroendocrine tumors frequently associated with germline pathogenic variants in SDHB. Although large SDHB deletions are rare worldwide, a recurrent 15,678 bp deletion encompassing the promoter region and exon 1 has been described in the Iberian Peninsula and Latin America, suggesting a founder effect.

Findings

We report three apparently unrelated Brazilian patients with paragangliomas carrying the same heterozygous germline SDHB exon 1 deletion (NM_003000.3: c.1-10413_73-3866del; g.17043962_17059585del). Clinical presentation was heterogeneous, including early-onset secretory paragangliomas and one patient with the 3P association (pheochromocytoma, paraganglioma, and pituitary adenoma). All tumors were surgically treated, and long-term follow-up showed favorable outcomes without metastatic disease. Breakpoint and haplotype analyses confirmed identity with the previously reported Iberian founder variant, supporting a shared ancestral origin.

Conclusion

These findings reinforce the high prevalence of this deletion in Brazil and its relevance for targeted genetic testing, family screening, and long-term surveillance strategies.

Förderung

  • Universidade Federal Do Rio De Janeiro

Zitieren

APA

Araujo, P. B., Nascimento, J. B., Carvallo, M. S., Miranda-Alves, L., Lourenço, D. M., Naliato, E. O., Miranda, M. H. V., Neto, S. H. D. C., Vidal, A. P. A., Pinto, M., Soares, P., Lima, J., & Violante, A. H. D. (2026). Founder SDHB Exon 1 Deletion in Brazilian Patients with Paraganglioma: Further Evidence for An Iberian Founder Effect. Current Genetic Medicine Reports, 14(1). https://doi.org/10.1007/s40142-026-00260-7

Vancouver

Araujo PB, Nascimento JB, Carvallo MS, Miranda-Alves L, Lourenço DM, Naliato EO, et al. Founder SDHB Exon 1 Deletion in Brazilian Patients with Paraganglioma: Further Evidence for An Iberian Founder Effect. Current Genetic Medicine Reports. 2026;14(1). doi:10.1007/s40142-026-00260-7

BibTeX
@article{Araujo2026,
  author = {Araujo, Paula Bruna and Nascimento, João Bosco and Carvallo, Mirna Sanchez and Miranda-Alves, Leandro and Lourenço, Delmar Muniz and Naliato, Erika O. and Miranda, Mateus Henrique Veloso and Neto, Silvio H. da Cunha and Vidal, Ana Paula Aguiar and Pinto, Mafalda and Soares, Paula and Lima, Jorge and Violante, Alice Helena Dutra},
  title = {Founder SDHB Exon 1 Deletion in Brazilian Patients with Paraganglioma: Further Evidence for An Iberian Founder Effect},
  journal = {Current Genetic Medicine Reports},
  year = {2026},
  volume = {14},
  number = {1},
  doi = {10.1007/s40142-026-00260-7}
}
Kostenlos starten →